Jump to content

AR - V7 - Resistance to Enzalutamide and Aberiterone


Charles (Chuck) Maack

Recommended Posts

Charles (Chuck) Maack

AR-V7 is an androgen receptor variant which, if found in the blood stream, disables the effectiveness of either Xtandi/enzalutamide or Zytiga/abiraterone acetate.

 

I have prepared a summary of recent research about AR-V7 which is available at http://tinyurl.com/qbgpezo

 

[Ed - Chuck's paper mentions blood tests for Circulating Tumour Cells (CTC) and AR-V7.  These tests are not routinely available in Australia.]

Link to post
Share on other sites
×
×
  • Create New...